ser64

Another Government Approval, Same Setup as Last Time

ロング
NASDAQ:MOTS   None
As in January when MOTS had a patent granted by the US and got clearance from the EU, this time they got FDA clearance for their solution for Upper GI Endoscopies. We are seeing the same magnitude of candles on the 2h and 4h charts. I think for a scalp, if you can get in below 1.5, you can hit 1.62 before a pull back in the first few minutes. Otherwise, I think 1.65-1.75 is a solid entry for a run up with key levels at 1.85, 2.05, 2.2, 2.4, 2.6, and 2.7. After 2.05, personally I'll set a ~10% (depending on my entry) trail stop for the entire position.
免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。